Novo Nordisk and UNICEF are expanding their collaboration to support efforts aimed at preventing overweight and obesity among children, as rising childhood obesity rates become an increasing global health concern.…
Ultragenyx Pharmaceutical (RARE.O) announced on Thursday that it has set a U.S. list price of $3.95 million for its recently licensed gene therapy Fayuvi, introducing one of the most costly…
The Swiss pharmaceutical company's shares fell almost 11% on its worst trading day ever on Tuesday after Novartis (NOVN.S) announced that its experimental medication for a muscle-wasting illness had failed…
A setback to the Swiss pharmaceutical company's attempts to revitalize its therapeutic pipeline occurred on Friday when Novartis (NOVN.S), opens new tab, announced that its experimental medication pelacarsen did not…
Today, we highlight two preliminary studies: one suggests a potential strategy to stop chemotherapy treatments from damaging nerves, and the other uncovers hitherto unknown consequences of germs that are known…
Nestle (NESN.S) announced on Thursday that it will invest 2 billion reais ($392.73 million) in its nutrition and health division in Brazil until 2028, including 600 million reais for a…
36 genes that significantly increase the incidence of chronic tic disorders and obsessive-compulsive disorder have been found by researchers; this finding may result in novel treatments. While chronic tic disorders,…
In an attempt to overtake rival Eli Lilly (LLY.N) in the second-largest pharmaceutical market in the world, Novo Nordisk (NOVOb.CO), opens new tab, announced on Thursday that China's drug regulator…
The U.S. Food and Drug Administration announced on Tuesday that it had approved Abbott Laboratories' (ABT.N) new tab glucose monitor, making it the first gadget that continually checks blood sugar…
The U.S. Food and Drug Administration has approved a new tab blood test for Roche (ROPC.S) and Eli Lilly's (LLY.N) to assist detect indications of Alzheimer's disease in those with…
